¼¼°èÀÇ ½Ã°¢ Àå¾Ö ½ÃÀå
Visual Impairment
»óǰÄÚµå : 1757897
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 06¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 274 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,053,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,161,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

¼¼°èÀÇ ½Ã°¢ Àå¾Ö ½ÃÀåÀº 2030³â±îÁö 70¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 47¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ¼¼°èÀÇ ½Ã°¢ Àå¾Ö ½ÃÀåÀº 2024-2030³â¿¡ CAGR 6.9%·Î ¼ºÀåÇϸç, 2030³â¿¡´Â 70¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ ¸®Æ÷Æ®¿¡¼­ ºÐ¼®ÇÑ ºÎ¹®ÀÇ ÇϳªÀÎ ±³À° ±â±â & ¼ÒÇÁÆ®¿þ¾î´Â CAGR 5.5%¸¦ ±â·ÏÇϸç, ºÐ¼® ±â°£ Á¾·á½Ã¿¡´Â 41¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ¸ðºô¸®Æ¼ µð¹ÙÀ̽º ºÐ¾ßÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ Áß CAGR 9.2%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 13¾ï ´Þ·¯, Áß±¹Àº CAGR 10.6%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ½Ã°¢ Àå¾Ö ½ÃÀåÀº 2024³â¿¡ 13¾ï ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ÀÇ °æÁ¦´ë±¹ÀÎ Áß±¹Àº 2030³â±îÁö 14¾ï ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, ºÐ¼® ±â°£ÀÎ 2024-2030³âÀÇ CAGRÀº 10.6%¿¡ ´ÞÇÕ´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖÀ¸¸ç, ºÐ¼® ±â°£ Áß CAGRÀº °¢°¢ 3.5%¿Í 6.6%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR 4.5%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ "½Ã°¢ Àå¾Ö" ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

¿Ö '½Ã°¢ Àå¾Ö'¿¡ ´ëÇÑ ´ëÀÀÀÌ Àü ¼¼°è ÇコÄɾîÀÇ ¿ì¼±¼øÀ§°¡ µÇ°í Àִ°¡?

¼¼°è 10¾ï ¸í ÀÌ»óÀÇ »ç¶÷µé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¡´Â '½Ã°¢Àå¾Ö'´Â »çȸÀû, °æÁ¦Àû, »îÀÇ Áú(QOL)¿¡ ±¤¹üÀ§ÇÏ°Ô ¿µÇâÀ» ¹ÌÄ¡±â ¶§¹®¿¡ °øÁߺ¸°ÇÀÇ ½Ã±ÞÇÑ °úÁ¦·Î ´ëµÎµÇ°í ÀÖ½À´Ï´Ù. ¹é³»Àå, ³ì³»Àå, ´ç´¢¸Á¸·º´Áõ, Ȳ¹Ýº¯¼º, ¹Ì±³Á¤ ±¼ÀýÀÌ»ó, ¼Ò¾Æ½Ç¸í µî Á¤»óÀûÀÎ ½Ã·ÂÀ» Á¦ÇÑÇÏ´Â ¸ðµç Áõ»óÀÌ ½Ã°¢Àå¾ÖÀÇ ¿øÀÎÀÔ´Ï´Ù. ±× ºÎ´ãÀº ¾È°ú ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ Á¢±ÙÀÌ Á¦ÇÑÀûÀÌ°í ¿¹¹æ ÀÇ·á°¡ ºÎÁ·ÇÑ ÁßÀú¼Òµæ ±¹°¡¿¡¼­ ºÒ±ÕÇüÀûÀ¸·Î ´õ Å®´Ï´Ù. Àα¸ÀÇ °í·ÉÈ­¿Í ´ç´¢º´°ú °°Àº ºñÀü¿°¼º ÁúȯÀÇ À¯ÇàÀ¸·Î ½Ã·Â ¼Õ½ÇÀÇ ¹ß»ý·üÀº Å©°Ô Áõ°¡ÇÒ °ÍÀ¸·Î ¿¹»óµÇ¸ç, WHO¿Í NGO¸¦ Æ÷ÇÔÇÑ Àü ¼¼°è º¸°Ç ±â°üÀº 'ÅëÇÕÀû Àΰ£ Á᫐ ¾È°ú ÀÇ·á(Integrated People-Centred Eye Care)' ±¸»óÀÇ Á¾ÇÕÀûÀÎ ¾È°ú ÀÇ·á ¸ðµ¨À» Àû±ØÀûÀ¸·Î ÃßÁøÇϰí ÀÖ½À´Ï´Ù. ÇöÀç ¿¹¹æ °¡´ÉÇÑ ½Ç¸íÀ» ¿¹¹æÇϱâ À§ÇØ Á¶±â Áø´Ü, Àú·ÅÇÑ Ä¡·á, Áö¿ª ±â¹Ý °³ÀÔ¿¡ ÁßÁ¡À» µÎ°í ÀÖ½À´Ï´Ù. µ¿½Ã¿¡, ´ëÁß ÀÎ½Ä °³¼± Ä·ÆäÀΰú Çб³ ±â¹Ý ½Ã·Â °Ë»ç ÇÁ·Î±×·¥À» ÅëÇØ Àú·ÅÇÑ °¡°ÝÀÇ ¾È°æ º¸Á¶±â±¸¿Í ½Ã·Â ÀúÇÏ Ãʱ⠴ܰèÀÇ °³ÀÔ¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù.

±â¼úÀº ½Ã·ÂÀúÇÏ Áø´Ü, ¸ð´ÏÅ͸µ, Ä¡·á¿¡ ¾î¶² Çõ¸íÀ» °¡Á®¿À°í Àִ°¡?

µðÁöÅÐ Çコ, ¿ÉÅäÀÏ·ºÆ®·Î´Ð½º, AIÀÇ À¶ÇÕÀº ´Ù¾çÇÑ ´Ü°è¿Í »óÅÂÀÇ ½Ã°¢ Àå¾Ö¸¦ °¨Áö, ¸ð´ÏÅ͸µ ¹× °ü¸®ÇÏ´Â ¹æ¹ýÀ» º¯È­½Ã۰í ÀÖ½À´Ï´Ù. ÈÞ´ë¿ë ¾ÈÀú Ä«¸Þ¶ó, ºû°£¼·´ÜÃþÃÔ¿µ±â(OCT), AI ±â¹Ý À̹ÌÁö ÀÎ½Ä ¼ÒÇÁÆ®¿þ¾îÀÇ Çõ½ÅÀ¸·Î ¸Á¸· ÁúȯÀ» Á¶±â¿¡ Á¤È®ÇÏ°Ô ¹ß°ßÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ½º¸¶Æ® ±Û·¡½º ¹× AI ±â¹Ý ½Ã°¢ º¸Á¶ Àåºñ¿Í °°Àº ¿þ¾î·¯ºí ±â±â´Â ½Ç½Ã°£ »óȲ ÇØ¼® ¹× ¹°Ã¼ ÀνÄÀ» Á¦°øÇÏ¿© ºÎºÐÀûÀ¸·Î ½Ã·ÂÀ» ÀÒÀº »ç¶÷µéÀÌ µ¶¸³ÀûÀ¸·Î Ž»öÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. °³¹ßÁßÀÎ ½º¸¶Æ® ÄÜÅÃÆ®·»Áî´Â ¾È¾Ð°ú Æ÷µµ´ç ¼öÄ¡¸¦ ¸ð´ÏÅ͸µÇÏ´Â ¼¾¼­¸¦ ÅëÇÕÇÏ¿© ³ì³»Àå ¹× ´ç´¢º´¼º ¸Á¸·Áõ¿¡ ´ëÇÑ Á¶±â °³ÀÔÀ» ¸ñÇ¥·Î ÇÕ´Ï´Ù. ½Ã¼± ÃßÀû ¹× ´ëºñ°¨µµ °Ë»ç ±â´ÉÀ» °®Ãá ¸ð¹ÙÀÏ ¾ÛÀº ƯÈ÷ ¿Üµý Áö¿ªÀ̳ª ÀÇ·á ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ª¿¡¼­ ½Ã·Â °Ë»ç¿¡ ´ëÇÑ Á¢±Ù¼ºÀ» ¹ÎÁÖÈ­Çϰí ÀÖ½À´Ï´Ù. Ŭ¶ó¿ìµå ±â¹Ý Ç÷§Æû°ú ¿ø°Ý ¾È°ú ¼­ºñ½º´Â ³óÃÌ Áø·á¼Ò¿Í µµ½Ã Àü¹®°¡¸¦ ¿¬°áÇÏ¿© Àü¹® ¾È°ú Áø·áÀÇ ¹üÀ§¸¦ È®ÀåÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ À¯ÀüÀÚ Ä¡·á¿Í ¸Á¸· À̽ÄÀº À¯Àü¼º ½Ç¸í ȯÀÚÀÇ ºÎºÐÀû ½Ã·Â ȸº¹À» ¸ñÇ¥·Î ÇÏ´Â ÇÁ·ÐƼ¾î Çõ½ÅÀÇ ´ëÇ¥ÀûÀÎ »ç·ÊÀÔ´Ï´Ù. ÀÌ·¯ÇÑ ±â¼ú Çõ½ÅÀº ÀÓ»ó °á°ú¸¦ °³¼±ÇÒ »Ó¸¸ ¾Æ´Ï¶ó ´Ù¾çÇÑ Á¤µµÀÇ ½Ã·Â ¼Õ½Ç Á¤µµ¿¡ ¸Â´Â º¸Á¶±â±¸ ¹× ÀçȰ¿ë Á¦Ç°ÀÇ Áö¼Ó°¡´ÉÇÑ ½ÃÀåÀ» âÃâÇϰí ÀÖ½À´Ï´Ù.

»çȸ°æÁ¦Àû, Àα¸Åë°èÇÐÀû µ¿ÇâÀÌ ½ÃÀå ´ÏÁ À籸¼ºÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

¼¼°è Àα¸ Åë°èÇÐÀû º¯È­, µµ½ÃÈ­, ¶óÀÌÇÁ½ºÅ¸ÀÏÀÇ º¯È­´Â ½Ã°¢ Àå¾ÖÀÇ À¯º´·ü°ú ÇÁ·ÎÆÄÀÏ¿¡ Á÷Á¢ÀûÀÎ ¿µÇâÀ» ¹ÌÄ¡¸ç, ÇコÄɾîÀÇ ¿ì¼±¼øÀ§¿Í ½ÃÀå Àü·«ÀÇ ÀüȯÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ƯÈ÷ ÀϺ», µ¶ÀÏ, Áß±¹, ¹Ì±¹ µîÀÇ ±¹°¡¿¡¼­´Â °í·ÉÈ­°¡ ÁøÇàµÇ¸é¼­ Ȳ¹Ýº¯¼º, ¹é³»Àå µî ³ëÈ­ °ü·Ã ¾ÈÁúȯÀÌ ±ÞÁõÇϰí ÀÖ½À´Ï´Ù. µ¿½Ã¿¡ Àü ¼¼°è¿¡¼­ ½ºÅ©¸° »ç¿ë ½Ã°£ Áõ°¡¿Í µðÁöÅÐ ±â±â¿¡ ´ëÇÑ ÀÇÁ¸µµ°¡ ³ô¾ÆÁö¸é¼­ ÀþÀº ÃþÀÇ ½Ã°¢ ÇÇ·Î, µðÁöÅÐ ´«ÀÇ ÇÇ·Î, Á¶±â ±Ù½Ã¸¦ ¾ÇÈ­½Ã۰í ÀÖ½À´Ï´Ù. µµ½É¿¡¼­´Â °øÇØ¿Í ½Ç³» Á¶¸í ºÎÁ·µµ ½Ã·Â ÀúÇÏÀÇ ¿øÀÎÀÌ µÇ°í ÀÖ½À´Ï´Ù. ÇÑÆí, ±³À°¿¡ ´ëÇÑ Á¢±Ù¼ºÀÌ Çâ»óµÇ°í ´« °Ç°­¿¡ ´ëÇÑ ÀνÄÀÌ ³ô¾ÆÁü¿¡ µû¶ó ¿¹¹æÀû ¾È°ú ÀÇ·á ¹× ½Ã·Â ±³Á¤ ¼­ºñ½º¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. °¢±¹ Á¤ºÎ´Â ±¹°¡ º¸°Ç ÇÁ·Î±×·¥ ¹× Çб³ Ä¿¸®Å§·³¿¡ ½Ã·Â °Ë»ç¸¦ Æ÷ÇÔ½ÃÅ´À¸·Î½á ÀÌ¿¡ ´ëÀÀÇϰí ÀÖ½À´Ï´Ù. ¾È°ú ÀÇ·á ¼­ºñ½º¿¡ ´ëÇÑ º¸Çè Àû¿ë ¹üÀ§´Â ƯÈ÷ ½ÅÈï °æÁ¦±¹¿¡¼­ È®´ëµÇ°í ÀÖÀ¸¸ç, ÀÌ´Â ¿Ü°úÀû °³ÀÔ, ±¤ÇÐ Á¦Ç° ¹× º¸Á¶ ±â¼úÀÇ »ç¿ëÀ» ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ´Ù±¹Àû ±â¾÷ ¹× ½Å»ý ±â¾÷Àº ¼º¼÷ ½ÃÀå°ú ½ÅÈï ½ÃÀå ¸ðµÎ¿¡ ¼­ºñ½º¸¦ Á¦°øÇϱâ À§ÇØ ÃÊÁ¡ Á¶ÀýÀÌ °¡´ÉÇÑ ¾È°æ¿¡¼­ ¸ð¹ÙÀÏ ±¼Àý ŰƮ¿¡ À̸£±â±îÁö Àúºñ¿ëÀÇ È®Àå °¡´ÉÇÑ ¼Ö·ç¼ÇÀ» °¡Áö°í ÀÌ ºÐ¾ß¿¡ ÁøÃâÇϰí ÀÖ½À´Ï´Ù. ±× °á°ú, ½Ã°¢Àå¾Ö »ýŰè´Â ¼ÒºñÀÚ ¼ö¿ä¿Í Á¤Ã¥Àû Áö¿ø¿¡ ÈûÀÔ¾î »çÈÄ ´ëÀÀÇü Ä¡·á¿¡¼­ »çÀü ´ëÀÀÇü °ü¸®·Î ÀüȯµÇ°í ÀÖ½À´Ï´Ù.

½Ã°¢Àå¾Ö ¼Ö·ç¼Ç ½ÃÀåÀÇ ¼¼°è È®´ë ¿øµ¿·ÂÀº?

½Ã°¢ Àå¾Ö ½ÃÀåÀÇ ¼ºÀåÀº ÁøÈ­ÇÏ´Â ÀÇ·á ¼­ºñ½º Á¦°ø ¸ðµ¨, ¸¸¼ºÁúȯ À¯º´·ü Áõ°¡, ¼ÒºñÀÚ Áß½ÉÀÇ ±â¼ú Çõ½Å µî ¿©·¯ °¡Áö ¿äÀο¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. ´ç´¢º´, °íÇ÷¾Ð, ³ëÈ­ °ü·Ã ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ´ç´¢º´¼º ¸Á¸·Áõ ¹× ³ì³»Àå°ú °°Àº µ¹ÀÌų ¼ö ¾ø´Â ¾ÈÁúȯÀÇ Àü ¼¼°è ¹ßº´·ü Áõ°¡¿¡ ±â¿©Çϰí ÀÖÀ¸¸ç, ÀÌ¿¡ µû¶ó Æò»ý ¸ð´ÏÅ͸µ ¹× Ä¡·á ¼Ö·ç¼ÇÀÌ ÇÊ¿äÇÏ°Ô µÇ¾ú½À´Ï´Ù. ÆèÅäÃÊ ·¹ÀÌÀú, ÃÊÀ½ÆÄ À¯È­ÈíÀÔ ½Ã½ºÅÛ, Á¢ÀÌ½Ä Àΰø¼öÁ¤Ã¼ µî ¾È°ú ¼ö¼ú ±â¼úÀÇ ¹ßÀüÀ¸·Î ½Ã·Â ȸº¹ ¼ö¼úÀÌ ´õ¿í Ä£¼÷Çϰí È¿°úÀûÀÏ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ƯÈ÷ µµ½ÃÈ­°¡ ºü¸£°Ô ÁøÇàµÇ´Â Áö¿ª¿¡¼­´Â ó¹æ ¾È°æ, ÄÜÅÃÆ®·»Áî, ¾à½Ã º¸Á¶±â±¸ µî ½Ã·Â±³Á¤ Á¦Ç°ÀÇ °¡¿ë¼º°ú °¡°ÝÀÌ È®´ëµÇ°í ÀÖ´Â °Íµµ Å« ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. µðÁöÅÐ ÀÇ·á Çõ¸íÀº ¿ø°ÝÀÇ·á, AI Áø´Ü, ¿ø°Ý ¸ð´ÏÅ͸µ ¼Ö·ç¼ÇÀ» ÅëÇØ ¾È°ú ÀÇ·á¿¡ ´ëÇÑ ±¤¹üÀ§ÇÑ ºÐ»êÇü Á¢±ÙÀ» °¡´ÉÇÏ°Ô ÇÔÀ¸·Î½á ½ÃÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù. ´Ù±â´É ±¤ÇÐ ±â±â ¹× ¿þ¾î·¯ºí ½Ã·Â ±â¼ú¿¡ ´ëÇÑ ¼ÒºñÀÚÀÇ ¼±È£µµ º¯È­µµ »õ·Î¿î Á¦Ç° Ä«Å×°í¸®¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. °ø°ø-¹Î°£ ÆÄÆ®³Ê½Ê°ú NGO ÁÖµµÀÇ Ä·ÆäÀÎÀ» Æ÷ÇÔÇÑ ¼¼°è ÀÚ±Ý Á¶´Þ ±¸»óÀº ÀÇ·á ¼­ºñ½º°¡ ºÎÁ·ÇÑ Áö¿ª¿¡¼­ ¾È°ú ÀÇ·á ÀÎÇÁ¶ó¸¦ °³¹ßÇÏ´Â Ã˸ÅÁ¦°¡ µÇ°í ÀÖ½À´Ï´Ù. º¸ÆíÀû ¾È°ú ÀÇ·á¿¡ ´ëÇÑ Á¤Ã¥Àû °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó ÀÌ·¯ÇÑ ÈûÀÌ ÇÕÃÄÁ® ½Ã°¢Àå¾Ö ¼Ö·ç¼Ç ½ÃÀåÀº Áö¼ÓÀû À̰í Á¾ÇÕÀûÀÎ ¼ºÀåÀ» ÀÌ·ê ¼ö ÀÖÀ» °ÍÀ¸·Î º¸ÀÔ´Ï´Ù.

ºÎ¹®

Á¦Ç° À¯Çü(±³À° ±â±â¡¤¼ÒÇÁÆ®¿þ¾î, À̵¿ ±â±â); ÃÖÁ¾»ç¿ëÀÚ(¸Í¾Æ Çб³¡¤ÈƷüÒ, ±â¾÷¡¤»çȸ ´Üü, °³Àοë, º´¿ø, ±âŸ ÃÖÁ¾»ç¿ëÀÚ)

Á¶»ç ´ë»ó ±â¾÷ÀÇ ¿¹(ÁÖ¸ñ 34»ç)

AI ÅëÇÕ

¿ì¸®´Â À¯È¿ÇÑ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI Åø¿¡ ÀÇÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ º¯ÇõÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â ÀϹÝÀûÀÎ LLM³ª ¾÷°èº° SLM Äõ¸®¿¡ µû¸£´Â ´ë½Å¿¡, ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ´ë·® ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî, Àü ¼¼°è Àü¹®°¡·ÎºÎÅÍ ¼öÁýÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇß½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¼öÀÔ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå °³¿ä

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

KSA
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Visual Impairment Market to Reach US$7.0 Billion by 2030

The global market for Visual Impairment estimated at US$4.7 Billion in the year 2024, is expected to reach US$7.0 Billion by 2030, growing at a CAGR of 6.9% over the analysis period 2024-2030. Educational Devices & Software, one of the segments analyzed in the report, is expected to record a 5.5% CAGR and reach US$4.1 Billion by the end of the analysis period. Growth in the Mobility Devices segment is estimated at 9.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$1.3 Billion While China is Forecast to Grow at 10.6% CAGR

The Visual Impairment market in the U.S. is estimated at US$1.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$1.4 Billion by the year 2030 trailing a CAGR of 10.6% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.5% and 6.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.5% CAGR.

Global "Visual Impairment" Market - Key Trends & Drivers Summarized

Why Is Addressing Visual Impairment Becoming a Global Healthcare Priority?

Visual impairment, affecting over a billion people worldwide, has become an increasingly urgent public health concern due to its far-reaching social, economic, and quality-of-life implications. Defined as any condition that limits an individual’s ability to see to a normal degree - from moderate sight loss to complete blindness - visual impairment is caused by a spectrum of conditions including cataracts, glaucoma, diabetic retinopathy, macular degeneration, uncorrected refractive errors, and childhood blindness. The burden is disproportionately high in low- and middle-income countries, where access to eye care services is limited and preventive care is scarce. As populations age and non-communicable diseases such as diabetes become more prevalent, the incidence of vision loss is projected to rise substantially. Global health organizations, including the WHO and NGOs, are actively pushing for inclusive eye care models under the “Integrated People-Centred Eye Care” initiative. The emphasis is now on early diagnosis, affordable treatment, and community-based interventions to prevent avoidable blindness. Simultaneously, public awareness campaigns and school-based vision screening programs are increasing the demand for affordable optical aids and interventions at earlier stages of visual decline.

How Is Technology Revolutionizing Diagnosis, Monitoring, and Treatment of Vision Loss?

The convergence of digital health, optoelectronics, and AI is transforming how visual impairment is detected, monitored, and managed across different stages and conditions. Innovations in portable fundus cameras, optical coherence tomography (OCT), and AI-powered image recognition software are enabling earlier and more accurate detection of retinal diseases - often before symptoms manifest. Wearable devices like smart glasses and AI-driven visual aids are providing real-time scene interpretation and object recognition, allowing partially sighted individuals to navigate independently. Smart contact lenses under development are integrating sensors to monitor intraocular pressure and glucose levels, targeting early intervention for glaucoma and diabetic retinopathy. Mobile apps with eye-tracking and contrast sensitivity tests are democratizing access to vision screening, particularly in remote or underserved areas. Cloud-based platforms and teleophthalmology services are expanding the reach of specialized eye care by connecting rural clinics with urban experts. Moreover, gene therapies and retina implants represent frontier innovations aiming to restore partial vision in inherited blindness cases. These technological breakthroughs are not only enhancing clinical outcomes but are also creating a sustainable market for assistive and rehabilitative products tailored to individuals with varying degrees of sight loss.

Why Are Socioeconomic and Demographic Trends Reshaping Market Needs?

Changing global demographics, urbanization, and lifestyle behaviors are directly impacting the prevalence and profile of visual impairment, prompting a shift in healthcare priorities and market strategies. The aging population - particularly in countries like Japan, Germany, China, and the U.S. - is leading to a surge in age-related eye diseases such as macular degeneration and cataracts. At the same time, the global rise in screen time and digital device dependency is exacerbating visual fatigue, digital eye strain, and early-onset myopia in younger populations. In urban centers, pollution and poor indoor lighting are additional contributors to vision deterioration. Meanwhile, greater access to education and increased awareness of eye health are fueling the demand for preventative eye care and vision correction services. Governments are responding by integrating vision screening into national health programs and school curriculums. Insurance coverage for eye care services is expanding, especially in developed economies, which is encouraging the uptake of surgical interventions, optical products, and assistive technologies. Multinational companies and startups are entering the space with low-cost, scalable solutions - from adjustable-focus eyeglasses to mobile refraction kits - to serve both mature and emerging markets. As a result, the visual impairment ecosystem is transitioning from reactive care to proactive management, driven by both consumer demand and policy support.

What’s Driving the Global Expansion of the Visual Impairment Solutions Market?

The growth in the visual impairment market is driven by several factors rooted in evolving healthcare delivery models, rising chronic disease incidence, and consumer-centered technological innovation. The increasing prevalence of diabetes, hypertension, and aging-related conditions is contributing to a higher global incidence of irreversible eye diseases such as diabetic retinopathy and glaucoma, necessitating lifelong monitoring and treatment solutions. Advancements in ophthalmic surgical technologies - including femtosecond lasers, phacoemulsification systems, and foldable intraocular lenses - are making vision restoration procedures more accessible and effective. A significant driver is the expanding availability and affordability of vision correction products such as prescription eyeglasses, contact lenses, and low-vision aids, particularly in rapidly urbanizing regions. The digital health revolution is further propelling the market, with telemedicine, AI diagnostics, and remote monitoring solutions enabling widespread, decentralized access to eye care. Changing consumer preferences for multifunctional optical devices and wearable vision tech are also creating new product categories. Global funding initiatives, including public-private partnerships and NGO-led campaigns, are catalyzing eye health infrastructure development in underserved areas. These converging forces - along with heightened policy focus on universal eye health - are positioning the visual impairment solutions market for sustained and inclusive growth.

SCOPE OF STUDY:

The report analyzes the Visual Impairment market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product Type (Educational Devices & Software, Mobility Devices); End-Use (Blind Schools & Training institutes, Enterprises & Social Organizations, Personal Use, Hospitals, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â